Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    May 2017
  1. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available


  2. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Text format     Abstract available


    March 2017
  3. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  4. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  5. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  6. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


    January 2017
  7. BITTERMANN T, Goldberg DS, Bauer CM, Khungar V, et al
    Characterizing the risk of false-positive hepatocellular carcinoma in recipients transplanted with T2 MELD exceptions.
    Transplantation. 2017 Jan 25. doi: 10.1097/TP.0000000000001660.
    PubMed     Text format     Abstract available


  8. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available


  9. RICH N, Tanriover B, Singal AG, Marrero JA, et al
    Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Transplantation. 2017;101:e12-e19.
    PubMed     Text format     Abstract available


  10. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


    December 2016
  11. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  12. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  13. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    November 2016
  14. MURALI AR, Romero-Marrero C, Miller C, Aucejo F, et al
    Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Transplantation. 2016;100:2391-2397.
    PubMed     Text format     Abstract available


  15. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  16. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


    August 2016
  17. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  18. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  19. TAPPER EB, Hughes MS, Buti M, Dufour JF, et al
    The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  20. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  21. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  22. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


    June 2016
  23. HAN S, Yang JD, Sinn DH, Ko JS, et al
    Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  24. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  25. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


    April 2016
  26. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  27. KIMURA K, Shirabe K, Yoshizumi T, Takeishi K, et al
    Ischemia-Reperfusion Injury in Fatty Liver Is Mediated by Activated NADPH Oxidase 2 in Rats.
    Transplantation. 2016;100:791-800.
    PubMed     Text format     Abstract available


    March 2016
  28. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  29. KHORSANDI SE, Yip VS, Cortes M, Jassem W, et al
    Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  30. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  31. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  32. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  33. ZHOU H, Zhu J, Yue S, Lu L, et al
    The Dichotomy of Endoplasmic Reticulum Stress Response in Liver Ischemia-Reperfusion Injury.
    Transplantation. 2016;100:365-72.
    PubMed     Text format     Abstract available


    January 2016
  34. POURCHER G, El-Kehdy H, Kanso F, Groyer-Picard MT, et al
    Volumetric Portal Embolization: A New Concept to Improve Liver Regeneration and Hepatocyte Engraftment.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  35. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  36. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  37. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  38. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  39. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  40. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    November 2015
  41. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  42. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  43. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    September 2015
  44. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  45. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  46. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  47. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  48. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  49. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    June 2015
  50. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    May 2015
  51. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  52. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  53. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  54. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    March 2015
  55. SCHIEFER J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, et al
    Alterations of Endothelial Glycocalyx During Orthotopic Liver Transplantation in Patients With End-Stage Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    February 2015
  56. MANCIA C, Loustaud-Ratti V, Carrier P, Naudet F, et al
    Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    January 2015
  57. OEZCELIK A, Dayangac M, Guler N, Yaprak O, et al
    Living Donor Liver Transplantation in Patients 70 Years or Older.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: